期刊文献+

胰岛素泵在糖尿病患者围手术期的应用观察 被引量:1

The application of insulin pump in diabetic patients
原文传递
导出
摘要 目的评价胰岛素泵(CSⅡ)在糖尿病患者围手术期的应用效果与作用。方法糖尿病围手术期患者37例随机分为两组,19例采用胰岛素泵持续皮下注射(CSⅡ组),18例采用多次皮下注射(MSⅡ组)。比较血糖控制水平、术前准备时间、术后持续肠内营养时血糖控制水平、伤口愈合情况等。结果两组治疗前血糖水平差异无统计学意义(P〉0.5),治疗后血糖下降水平及血糖稳定水平CSⅡ组比MSⅡ组好,差异有统计学意义(P〈0.01)。CSⅡ组术前准备时间及住院时间明显缩短,术前、术后及术后肠内营养时血糖控制稳定,伤口愈合良好。结论胰岛素泵用于糖尿病患者围手术期的治疗是顺利手术、减少并发症、减少患者负担的有效方法。 Objective To evaluate the effect of insulin pumps in diabetic patients. Methods Perioperative 37 diabetic patients in our hospital were randomly divided into two groups;19 patients were given continuous insulin pump subcutaneously ( CS Ⅱ ) , 18 multiple subcutaneous injection ( MS Ⅱ) , comparing the level of blood sugar control, pre-operative time, control of blood sugar levels, wound healing, and so on, postoperative enteral nutrition. Results Two groups of blood glucose levels before treatment had no significant difference ( P 〉 0. 5 ), after treatment the de- creased level of blood sugar and blood sugar level of stability in the CS Ⅱ group better than the MS Ⅱ group, the difference was significant( P 〈 0. 01 ). CS Ⅱ significantly shortened the pre-operative preparation time, before and after operation and postoperative enteral nutrltion,control of blood sugar stable, the wound healed well and shortened hospital stay. Conclusion Insulin pump is an effective manner in the perioperative treatment of diabetes for smoothing operation, reducing the burden on patients and complications.
出处 《中国基层医药》 CAS 2009年第1期62-63,共2页 Chinese Journal of Primary Medicine and Pharmacy
关键词 糖尿病 胰岛素输注系统 围手术期 Diabetes mellitus Insulin infusion systems Perioperative
  • 相关文献

参考文献5

二级参考文献31

  • 1[1]Kaul CL, Ramarao P. Sympathetic nervous system and experimental diabetes: role of adrenal medullary hormones. Prog Drug Res,2001,57:163-180.
  • 2[2]Soucek M, Kara T. Stress-induced hypertension and diabetes mellitus. Vnitr Lek,2001,47:315-319.
  • 3[3]Bjorntorp P, Rossner S, Udden J. Stress-induced increased cortisol levels result in leptin resistand obesity. Lakartidningen,2001,98:5458-5461.
  • 4[4]Gehlert DR. Role of hypothalamic neuropeptide Y in feeding and obesity. Neuropeptides,1999,33:329-332.
  • 5[5]Marsh DJ, Hollopeter GK, Afer KE, et al. Role of the Y5 neuropeptide Y receptor in feeding and obesity. Nat Med,1998,4:718-720.
  • 6[6]Grow JP, Beckman JS. Reaction between nitric oxide, superoxide and peroxynitrite: footprints of peroxynitrite in vivo. Adv Pharmacol,1998,34:17-20.
  • 7[7]Elenkov IJ, Webster EL, Torpy DJ, et al. Stress, corticotropin-releasing hormone, glucocorticoids, and the immune/inflammatory response: Acute and chronic effects. Ann N Y Acad Sci,1999,876:1-6.
  • 8[8]Maegawa H, Kashiwagi A. Molecular mechanism and clinical impact of insulin resistance in type 2 diabetes mellitus. Nippon Rinsho,1999,57:539-543.
  • 9[9]Storz P, Doppler H, Wering A, et al. TNF inhibits insulin induced STAT5 activation in differentiated mouse muscle cells pmi28. FEBS Lett,1998,27:440-441.
  • 10[10]Miura A, Ishizuka T, Kanoh Y, et al. Effect of tumor necrosis factor-alpha on insulin signal transduction in rat adipocytes: relation to PKC beta and zeta translocation. Biochem Biophys. Acta,1999,1449:227-232.

共引文献129

同被引文献9

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部